GetTopicDetailResponse(id=a56ae28167, topicName=FcRn, introduction=FcRn, content=null, image=null, comments=3, allHits=1233, url=https://h5.medsci.cn/topic?id=7281, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=101934, tagList=[TagDto(tagId=101934, tagName=FcRn)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2255371, encodeId=b4c822553e158, content=<a href='/topic/show?id=010c9506a3' target=_blank style='color:#2F92EE;'>#IgG#</a> <a href='/topic/show?id=a56ae28167' target=_blank style='color:#2F92EE;'>#FcRn#</a>, objectTitle= 帶你了解新生兒Fc受體（FcRn）, objectType=article, longId=866349, objectId=4a4286634954, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240509/1715223995977_5579292.jpg, objectUrl=/article/show_article.do?id=4a4286634954, replyNumber=0, likeNumber=46, createdTime=2025-03-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=4a4286634954, moduleTitle= 帶你了解新生兒Fc受體（FcRn）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4a4286634954)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1968668, encodeId=a71f19686682f, content=<a href='/topic/show?id=a56ae28167' target=_blank style='color:#2F92EE;'>#FcRn#</a>, objectTitle=Front Immunol：靶向FcRN：治療天皰瘡的新途徑, objectType=article, longId=218626, objectId=2ceb21862692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ceb21862692, replyNumber=0, likeNumber=87, createdTime=2022-05-03, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ceb21862692, moduleTitle=Front Immunol：靶向FcRN：治療天皰瘡的新途徑, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2ceb21862692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968667, encodeId=31ca196866e65, content=<a href='/topic/show?id=a56ae28167' target=_blank style='color:#2F92EE;'>#FcRn#</a>, objectTitle=Blood：FcRn可放大IgG免疫復(fù)合物對組織因子活性的誘導(dǎo), objectType=article, longId=190568, objectId=c51d1905682d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c51d1905682d, replyNumber=0, likeNumber=97, createdTime=2021-02-25, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c51d1905682d, moduleTitle=Blood：FcRn可放大IgG免疫復(fù)合物對組織因子活性的誘導(dǎo), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c51d1905682d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968666, encodeId=4ed31968666e6, content=<a href='/topic/show?id=a56ae28167' target=_blank style='color:#2F92EE;'>#FcRn#</a>, objectTitle=AAN：Immunovant宣布其用于治療重癥肌無力的抗FcRn單抗IMVT-1401，在健康受試者中耐受良好, objectType=article, longId=165921, objectId=14c71659215e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14c71659215e, replyNumber=0, likeNumber=73, createdTime=2020-02-03, rootId=0, userName=zgwhgch, userId=10ba218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14c71659215e, moduleTitle=AAN：Immunovant宣布其用于治療重癥肌無力的抗FcRn單抗IMVT-1401，在健康受試者中耐受良好, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=14c71659215e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
